JB/CALL/DOCMORRIS/75/0.05/21.06.24 Stock

JB/CALL/DOCMORRIS/75/0.05/21.06.24 Share Price

DOZQJB

CH1284784019

Real-time Bid/Ask 12:30:54 17/06/2024 pm IST
0.001 ^CHF / 0.011 ^CHF	-45.45%

Current month	-87.78%
1 month	-96.21%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DOCMORRIS AG

Chart JB/CALL/DOCMORRIS/75/0.05/21.06.24

Latest news about DOCMORRIS AG

DOCMORRIS : Jefferies gives a Buy rating	05/06	ZD
DOCMORRIS : Receives a Sell rating from UBS	04/06	ZD
DocMorris : AGM Minutes 2024	30/05	PU
Warburg: Several mid-caps attractive takeover targets - and Mercedes-Benz	27/05	DP

More news

Quotes 5-day view

Date	Price	Change
14/24/14	0.011	-8.33%
13/24/13	0.012	-40.00%
11/24/11	0.02	-33.33%
10/24/10	0.03	-25.00%

Delayed Quote Swiss Exchange

Last update June 14, 2024 at 08:50 pm IST

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	DOCMORRIS AG
Issuer	Bank Julius Bär
	DOZQJB
ISIN	CH1284784019
Date issued	30/08/2023
Strike	75 CHF
Maturity	21/06/2024 (4 Days)
Parity	20 : 1
Emission price	0.59 CHF
Emission volume	N/A
Settlement	les deux
Currency	CHF

Technical Indicators

Highest since issue	1.42 CHF
Lowest since issue	0.011 CHF
Delta	0.04x
Omega	19.04
Premium	28.85x
Gearing	485.83x
Moneyness	0.7773
Difference Strike	18.35 CHF
Difference Strike %	+24.47%
Spread	0.01 CHF
Spread %	90.91%
Theoretical value	0.006000
Implied Volatility	131.37 %
Total Loss Probability	97.12 %
Intrinsic value	0.000000
Present value	0.006000
Break even	75.12 CHF
Theta	-0.01x
Vega	0x
Rho	0x

Company Profile

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Sector

More about the company

Ratings for DocMorris AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DocMorris AG

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

58.45 CHF

Average target price

99 CHF

Spread / Average Target

+69.38%

Consensus